Related Experiment Video

Updated: Mar 2, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

Pathway for the Management of Atrial Fibrillation and Atrial Flutter

Eyal Herzog1, Edgar Argulian, Steven B Levy

  • 1From the Mount Sinai St. Luke's Hospital, New York, NY.

Critical Pathways in Cardiology
|May 17, 2017
PubMed

Insights

A new RACE pathway simplifies managing atrial fibrillation (AF) and atrial flutter (Afl). It integrates rate control, anticoagulation, cardioversion, and electrophysiology/antiarrhythmic medication for easier diagnosis and treatment.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia with increasing prevalence.
  • Current AF and atrial flutter (Afl) guidelines are complex and fragmented.
  • Existing guidelines are outdated, necessitating an updated management approach.

Purpose of the Study:

  • To develop a novel, user-friendly pathway for managing AF and Afl.
  • To simplify the diagnosis and initial management of these arrhythmias.
  • To provide a comprehensive therapeutic guideline using a structured acronym.

Main Methods:

  • Development of the RACE pathway acronym: Rate control, Anticoagulation therapy, Cardioversion, and Electrophysiology/antiarrhythmic medication.
  • Incorporation of key concepts for initial diagnosis and management.
  • Creation of a comprehensive therapy guideline based on the RACE framework.

Main Results:

  • The RACE pathway offers a simplified approach to AF and Afl management.
  • It consolidates essential management components into a memorable acronym.
  • The pathway aims to improve clinical practice by addressing guideline limitations.

Conclusions:

  • The RACE pathway provides a structured and accessible method for managing AF and Afl.
  • This novel approach addresses the complexity and fragmentation of existing guidelines.
  • The RACE pathway facilitates efficient and effective patient care for these common arrhythmias.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.6K
Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
547
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
716
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
426
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
386
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.4K